Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, or Mesothelioma

NCT00398138 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Leukemia
Lung Cancer
Malignant Mesothelioma
Myelodysplastic Syndromes
Primary Peritoneal Cavity Cancer

Interventions

BIOLOGICAL: WT-1 analog peptide vaccine
BIOLOGICAL: incomplete Freund's adjuvant
BIOLOGICAL: sargramostim
GENETIC: polymerase chain reaction
OTHER: flow cytometry
OTHER: immunoenzyme technique

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]
[object Object]